Shaker Mousa,
Shaker (Vice Provost for Research and Professor of Pharmacology, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA) Mousa,
Paul Davis,
Paul (Professor of Pharmacy, The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA) Davis
e.a.
Elsevier Science
e druk, 2016
9780128025765
Anti-Angiogenesis Strategies in Cancer Therapies
Specificaties
Paperback, blz.
|
Engels
Elsevier Science |
e druk, 2016
ISBN13: 9780128025765
Rubricering
Levertijd ongeveer 8 werkdagen
Samenvatting
Anti-angiogenesis Strategies in Cancer Therapeutics provides a detailed look at the current status and future directions in the discovery and development of novel anti-angiogenesis strategies in oncology. This book highlights the different mechanisms involved in the modulation of angiogenesis, including inflammation, thrombosis, and microRNA, and shows how nanotechnology can further enhance the potential of existing and new anti-angiogenesis approaches.
Written for industry scientists, researchers, oncologists, hematologists, and professors and students in the field, this comprehensive book covers all aspects of anti-angiogenesis strategies and their differences.
Specificaties
Inhoudsopgave
<p>1. Role of Angiogenesis and lymphogenesis in Cancer (tumor growth, Invasion, metastasis2. Role of Angiogenesis and anti-angiogenesis in hematological malignancies (acute / chronic leukemia, lymphoma, myelodysplastic syndromes, myeloproliferative neoplasms)3. The interface between Thrombosis-Inflammation and Angiogenesis4. Micro RNA and Angiogenesis modulation5. Preclinical discovery and development of different Pharmacological anti-angiogenesis agents6. Differences among different anti-angiogenesis strategies (Mechanisms of actions)7. Naturally Occurring Anti-angiogenesis8. Clinical trials with anti-angiogenesis agents: Approved agents9. Angiogenesis Biomarkers and Impact on personalized management10. Efficacy of Anti-VEGF therapy in cancer11. Nanotechnology in enhancing the utility of anti-angiogenesis agents – Combinations with other anti-cancer agents12. Multi-targeted anti-angiogenesis therapy in cancer13. Combination of anti-angiogenesis and chemotherapeutics14. Nanotechnology in enhancing the utility of anti-angiogenesis agents – Combinations with other anti-cancer agents15. Nano-targeted anti-angiogenesis agents in cancer detection16. Future Directions</p>